Sale!
Rated 5.00 out of 5 based on 1 customer rating
(1 customer review)

PT141 (10mg)

Original price was: $39.95.Current price is: $29.95.

Availability: 8 in stock

Research-Grade | 99%+ Purity | Third-Party Tested

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist structurally derived from Melanotan 2. Unlike many compounds that influence sexual function through vascular mechanisms, PT-141 operates centrally acting directly on melanocortin receptors in the brain, particularly MC3R and MC4R, to modulate sexual arousal pathways at the neurological level.

PT141 (10mg)

SKU pt141 Category

This central mechanism of action distinguishes PT-141 as a uniquely valuable research compound in the study of sexual dysfunction, libido regulation, and hypothalamic signaling. Its ability to engage the melanocortin system independent of hormonal or vascular pathways makes it particularly relevant for investigating the neurobiological foundations of sexual motivation and arousal in both male and female research models.

Beyond sexual function research, PT-141 is studied for its broader melanocortin system interactions, including inflammation modulation, blood pressure response, and autonomic nervous system signaling. Its well-characterized receptor binding profile and growing peer-reviewed literature make it a reliable tool for laboratories investigating neuroendocrine and behavioral research questions.

All vials are HPLC-validated and mass-spectrometry confirmed. Complete batch COA documentation is available upon request.

Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight: 1,025.17 g/mol
Storage: Lyophilized at −20°C | Reconstitute under sterile conditions

FOR RESEARCH USE ONLY

1 review for PT141 (10mg)

  1. Rated 5 out of 5

    Admin

    Clear 10 mg labeling, professional packaging, and easy-to-review research information. The focus on testing transparency and research-only positioning made a strong impression.

Add a review

Your email address will not be published. Required fields are marked *

COAS

PRODUCT BATCH TESTING ORDERED SAMPLE RECEIVED STATUS ACTION
BPC157 10mg 021 1 JULY 2025 7 JULY 2025 CURRENT View COA
IGF-1 LR3 1mg 020 2 APRIL 2026 13 APRIL 2026 CURRENT View COA
PT-141 021 2 FEB 2026 13 FEB 2026 CURRENT View COA
Retatrutide 20mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Semiglutide 10mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Semiglutide 30mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
TB-500 021 2 FEB 2026 13 FEB 2026 CURRENT View COA
Tesamorelin 10mg 021 1 JULY 2025 7 JULY 2025 CURRENT View COA
Tirzepatide 30mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Scroll to Top